Roche shows sterling opportunities for unrated credits with £250m 20 year hit
Swiss pharmaceuticals company Roche demonstrated the depth of demand for unrated credits in the sterling market yesterday (Thursday), when it increased its debut issue in the currency from £150m to £250m.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts